GRIDX

GRIDX stands as a premier venture capital fund, dedicated to fostering the growth of non-therapeutic biotech startups across Latin America. With a rich history spanning over 8 years, GRIDX has successfully connected groundbreaking Latin American science with vital venture capital through its innovative company-building program. Each year, GRIDX drives a transformative process for scientific and business talents, with the goal of co-founding startups that create disruptive solutions rooted in laboratory discoveries. GRIDX invests significantly in these promising ventures and ensures they are well-connected globally to facilitate scalable growth.

Located in Ciudad Autónoma de Buenos Aires, Buenos Aires at Teodoro García 2474, GRIDX not only provides essential initial funding but also supports subsequent funding rounds, investing up to USD 1 million. The company's commitment extends beyond financial support, offering strategic guidance and access to a vast network of industry experts, ensuring that each startup has the resources needed to thrive.

GRIDX is continually evolving to meet the needs of the dynamic biotech industry, with the support of the company’s management, further details and innovations will be revealed soon. We invite the manager of GRIDX to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional work and attract even more interest. GRIDX operates also in São Paulo, BR; Puebla, MX; 6201 Avenida Italia
Montevideo, 11500, UY